Tiziana Life Sciences ( (TLSA) ) has released a notification of late filing.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Tiziana Life Sciences Ltd has filed a Form 12b-25 to notify investors of a delay in submitting its Form 20-F (Yearly Report) for the financial year ended December 31, 2025. The postponed Form 20-F (Yearly Report) is the company’s annual filing with the U.S. Securities and Exchange Commission.
The company cites time constraints around compiling, distributing and reviewing the required information as the main reason for missing the original deadline. Management notes that filing on time would have imposed undue hardship and expense, but does not reference auditor changes, internal control failures or regulatory investigations.
Tiziana Life Sciences expects to file the delayed Form 20-F (Yearly Report) within 15 calendar days of the original due date, as allowed under the Form 12b-25 extension rules. This suggests the company anticipates only a short administrative delay rather than a protracted reporting issue.
The company indicates it does not expect any significant change in its results of operations compared with the prior fiscal year to be reflected in the upcoming report. Investors should remember that any discussion of expected timing or impact remains forward-looking and is subject to change if new information emerges.
Tiziana confirms that all other required periodic reports over the last 12 months have been filed, underscoring its intent to remain in good standing with U.S. disclosure rules. The notification is signed on behalf of the company by Chief Financial Officer Keeren Shah on April 30, 2026, signalling executive-level oversight of the delayed filing.
The most recent analyst rating on (TLSA) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Tiziana Life Sciences stock, see the TLSA Stock Forecast page.
More about Tiziana Life Sciences
Average Trading Volume: 150,336
Technical Sentiment Signal: Sell
Current Market Cap: $149.8M
Find detailed analytics on TLSA stock on TipRanks’ Stock Analysis page.